Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1999;93:219-222
© 1999 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHORGE, J. O.
Right arrow Articles by SHEETS, E. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHORGE, J. O.
Right arrow Articles by SHEETS, E. E.

ORIGINAL RESEARCH

Stage IA1 Cervical Adenocarcinoma: Definition and Treatment

JOHN O. SCHORGE, MD, KENNETH R. LEE, MD, CYNTHIA E. FLYNN, MD, ANNEKATHRYN GOODMAN, MD and ELLEN E. SHEETS, MD

From the Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Biology, and the Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts; the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, and the Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Address reprint requests to: John O. Schorge, MD Department of Obstetrics, Gynecology, and Reproductive Biology Brigham and Women’s Hospital 75 Francis Street Boston, MA 02115 E-mail: joschorge{at}bics.bwh.harvard.edu

Objective: To propose a definition for stage IA1 cervical adenocarcinoma, based on the International Federation of Gynecology and Obstetrics (FIGO) staging system, and to determine if patients meeting criteria might be candidates for conservative surgery.

Methods: Two hundred women were diagnosed with early-stage cervical adenocarcinoma from 1982 to 1996. Histopathologic sections were reviewed by a gynecologic pathologist. Medical records were reviewed, and patients included in this study had microscopically identifiable lesions, up to 3 mm invasive depth, up to 7 mm tumor width, and negative margins if cone biopsy was performed.

Results: Twenty-one patients with microinvasive adenocarcinoma met criteria for FIGO stage IA1 carcinoma of the cervix. The median (range) follow-up was 76 (30–172) months and median (range) patient age was 38 (24–75) years. Definitive treatment included type II or III radical hysterectomy in 16 cases, simple abdominal or vaginal hysterectomy in four cases, and loop electrosurgical excision procedure in one case; one patient received adjuvant pelvic radiation. The histologic subtypes were endocervical adenocarcinoma in 18 cases, adenosquamous carcinoma in two cases, and clear-cell adenocarcinoma in one case. There was no evidence of parametrial invasion or lymph node metastases in any patient who had radical surgery, and there were no disease recurrences.

Conclusion: Patients with microinvasive adenocarcinoma who met criteria for FIGO stage IA1 cervical carcinoma had disease limited to the cervix, and conservative surgery, such as cone biopsy or simple hysterectomy, might offer them definitive treatment.




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
M K Heatley
Dissection and reporting of the organs of the female genital tract
J. Clin. Pathol., March 1, 2008; 61(3): 241 - 257.
[Full Text] [PDF]


Home page
Obstet GynecolHome page
D. H. Moore
Cervical Cancer
Obstet. Gynecol., May 1, 2006; 107(5): 1152 - 1161.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
D. M. Gershenson
Fertility-Sparing Surgery for Malignancies in Women
J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 43 - 47.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
S.-W. Chen, J.-A. Liang, S.-N. Yang, and F.-J. Lin
Postoperative Radiotherapy for Patients with Invasive Cervical Cancer Following Treatment with Simple Hysterectomy
Jpn. J. Clin. Oncol., September 1, 2003; 33(9): 477 - 481.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
W G McCluggage
Endocervical glandular lesions: controversial aspects and ancillary techniques
J. Clin. Pathol., March 1, 2003; 56(3): 164 - 173.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
M. T. McHale, T. D. Le, R. A. Burger, M. Gu, J. L. Rutgers, and B. J. Monk
Fertility Sparing Treatment for In Situ and Early Invasive Adenocarcinoma of the Cervix
Obstet. Gynecol., November 1, 2001; 98(5): 726 - 731.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
J. C. WEBB, C. R. KEY, C. R. QUALLS, and H. O. SMITH
Population-Based Study of Microinvasive Adenocarcinoma of the Uterine Cervix
Obstet. Gynecol., May 1, 2001; 97(5): 701 - 706.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Obstetricians and Gynecologists.